Approvals/TGA/CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, Alu-Alu blister pack

Approved

STANDARD

CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, Alu-Alu blister pack

Hetero Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d2fea6e262ae615d
Product Name: CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, Alu-Alu blister pack
Artg Id: 297920
Artg Name: CAVADEXA 600/300 Abacavir (as sulfate) and Lamivudine 600mg/300mg tablets, blister pack
Sponsor: Hetero Australia Pty Ltd
Company Detail Path: /organization/hetero-australia-pty-ltd
Artg Date: 2022-12-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/19be25573db4ef9f8ec0750b1434d4b6.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

d2fea6e262ae615d

Type

Standard